ReNerve Quarterly Sales Top Full-Year FY26 Result
RNV: $0.089 -1.11% · MC: $14M
ReNerve reported record quarterly sales of approximately $584,000, up 176% on the previous quarter and 774% on the same quarter last year, exceeding its FY26 full-year sales. September was its first month with sales above $200,000; cash was approximately $2 million at quarter-end, with the company reporting 4.5 quarters of funding available including its undrawn facility.

Comments